1-7 of 7
Nina Bhardwaj, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune Checkpoint Blockade Enhances Mutated Calreticulin-Induced T Cell Immunity in Myeloproliferative Neoplasms

Cansu Cimen Bozkus, PhD, John P Finnigan, MDPhDStudent, John Mascarenhas, MD, Ronald Hoffman, MD, Nina Bhardwaj, MD PhD, Camelia Iancu-Rubin, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 384.
https://doi.org/10.1182/blood.V130.Suppl_1.384.384
Published: 2017
Journal Articles

Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies

Camelia Iancu-Rubin, PhD, Helen Fong, PhD, Goar Mosoyan, Ami Patel, MS, Rachel Sabado, PhD, Meseck Marcia, MS, Erin Moshier, MS, Umut Ozbek, PhD, Alla Keyzner, MD, Nina Bhardwaj, MD PhD, Ian K. McNiece, PhD, Jay Tong, MD, Ronald Hoffman, MD
Journal: Blood
Blood (2016) 128 (22): 818.
https://doi.org/10.1182/blood.V128.22.818.818
Published: 2016
Journal Articles

Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma

Deepak Perumal, PhD, Alessandro Lagana', PhD, Alex Rubinsteyn, PhD, John P Finnigan, Jr., BS, Pei-Yu Kuo, MS, Violetta V Leshchenko, PhD, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Jeff Hammerbacher, BA, Eric Schadt, PhD, Nina Bhardwaj, MD PhD, Samir Parekh, MD
Journal: Blood
Blood (2015) 126 (23): 1851.
https://doi.org/10.1182/blood.V126.23.1851.1851
Published: 2015
Journal Articles

Turning a Tumor into a Vaccine Factory: In Situ Vaccination for Low-Grade Lymphoma

Thomas Marron, MD PhD, Nina Bhardwaj, MD PhD, Elizabeth Crowley, Tibor Keler, PhD, Thomas A. Davis, MD, Joshua Brody, MD
Journal: Blood
Blood (2014) 124 (21): 5473.
https://doi.org/10.1182/blood.V124.21.5473.5473
Published: 2014
Journal Articles

Host Immune Responses Against CT Antigens in Multiple Myeloma Patients.

Nikoletta Lendvai, MD, PhD, Sacha Gnjatic, PhD, Erika Ritter, Yao-Tseng Chen, MD, PhD, Christina Coughlin, MD, PhD, Robert H. Vonderheide, MD, DPhil, Ruben Niesvizky, MD, Nina Bhardwaj, MD, PhD, Selina Chen-Kiang, PhD, Lloyd J. Old, MD, Hearn J. Cho, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3492.
https://doi.org/10.1182/blood.V108.11.3492.3492
Published: 2006
Journal Articles

Differential Expression of Type I MAGE in New and Relapsed Multiple Myeloma: Evidence for Association with Proliferation and Progression of Disease.

Hearn J. Cho, MD, PhD, Scott Ely, MD, Wayne R. Austin, AB, Ruben Niesvizky, MD, Roger Pearse, MD, PhD, Morton Coleman, MD, Nina Bhardwaj, MD, PhD, Maurizio DiLiberto, PhD, Selina Chen-Kiang, PhD, Lloyd J. Old, MD, Achim A. Jungbluth, MD
Journal: Blood
Blood (2006) 108 (11): 3397.
https://doi.org/10.1182/blood.V108.11.3397.3397
Published: 2006
Journal Articles

CT7 (MAGE-C1)-Specific Cellular Immune Responses in the Bone Marrow Microenvironment of Multiple Myeloma Patients.

Hearn J. Cho, MD, PhD, Len Farol, MD, Jonathan T. Truong, BA, Wayne R. Austin, AB, Yao-Tseng Chen, MD, Nina Bhardwaj, MD, PhD, Ruben Niesvizky, MD, Lloyd J. Old, MD, Selina Chen-Kiang, PhD
Journal: Blood
Blood (2005) 106 (11): 356.
https://doi.org/10.1182/blood.V106.11.356.356
Published: 2005